Title | Aerosol Risk with Noninvasive Respiratory Support in Patients with COVID-19. |
Publication Type | Journal Article |
Year of Publication | 2020 |
Authors | Miller DC, Beamer P, Billheimer D, Subbian V, Sorooshian A, Campbell BSalvagio, Mosier JM |
Journal | J Am Coll Emerg Physicians Open |
Date Published | 2020 May 21 |
ISSN Number | 2688-1152 |
Abstract | OBJECTIVES: This study evaluates aerosol production with high flow nasal cannula () and noninvasive positive pressure ventilation () compared to six liters per minute by low-flow nasal cannula. METHODS: Two healthy volunteers were randomized to control (six liters per minute by low-flow nasal cannula), NIPPV, or HFNC using block randomization. NIPPV conditions were studied using continuous positive airway pressures of 5, 10, and 15 cm HO with an FiO of 1.0 delivered via full-face mask. HFNC conditions included flow rates of 30 and 40 liters per minute with an FiO of 1.0 with and without coughing. HFNC and low-flow nasal cannula conditions were repeated with and without participants wearing a surgical mask. Six aerosol sizes (0.3, 1.0, 2.5, 5, and 10 μm) and total aerosol mass were measured at two feet and six feet from the participant's nasopharynx. RESULTS: There was no significant difference in aerosol production between either HFNC or NIPPV and control. There was also no significant difference with the use of procedural mask over the HFNC. There was significant variation between the two participants, but in neither case was there a difference compared to control. There was an aerosol-time trend, but there does not appear to be a difference between either flow rate, pressure, or control. Furthermore, there was no accumulation of total aerosol particles over the total duration of the experiment in both HFNC and NIPPV conditions. CONCLUSIONS: HFNC and NIPPV did not increase aerosol production compared to six liters per minute by low-flow nasal cannula in this experiment involving healthy volunteers.This article is protected by copyright. All rights reserved. |
DOI | 10.1002/emp2.12152 |
Alternate Journal | J Am Coll Emerg Physicians Open |
PubMed ID | 32838370 |
PubMed Central ID | PMC7280651 |
Grant List | P30 ES006694 / ES / NIEHS NIH HHS / United States |
Aerosol Risk with Noninvasive Respiratory Support in Patients with COVID-19.
Faculty Reference:
Jarrod Mosier, MD
Weight:
0